Takeda Pharmaceutical Company Limited (LON:0A87)

LON:0A87 Statistics

Total Valuation

LON:0A87 has a market cap or net worth of GBP 39.11 billion. The enterprise value is 61.63 billion.

Market Cap	39.11B
Enterprise Value	61.63B

Important Dates

The last earnings date was Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Sep 30, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	+1.77%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	46.23%
Float	1.58B

Valuation Ratios

The trailing PE ratio is 73.08.

PE Ratio	73.08
Forward PE	n/a
PS Ratio	1.85
PB Ratio	1.08
P/TBV Ratio	n/a
P/FCF Ratio	8.17
P/OCF Ratio	6.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.87, with an EV/FCF ratio of 12.87.

EV / Earnings	115.16
EV / Sales	2.92
EV / EBITDA	9.87
EV / EBIT	21.73
EV / FCF	12.87

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.71.

Current Ratio	1.19
Quick Ratio	0.54
Debt / Equity	0.71
Debt / EBITDA	4.09
Debt / FCF	5.36
Interest Coverage	4.62

Financial Efficiency

Return on equity (ROE) is 1.50% and return on invested capital (ROIC) is 2.76%.

Return on Equity (ROE)	1.50%
Return on Assets (ROA)	2.47%
Return on Invested Capital (ROIC)	2.76%
Return on Capital Employed (ROCE)	4.71%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	445,835
Profits Per Employee	11,277
Employee Count	47,455
Asset Turnover	0.29
Inventory Turnover	1.16

Taxes

In the past 12 months, LON:0A87 has paid 436.85 million in taxes.

Income Tax	436.85M
Effective Tax Rate	44.89%

Stock Price Statistics

The stock price has increased by +22.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+22.57%
50-Day Moving Average	13.66
200-Day Moving Average	13.79
Relative Strength Index (RSI)	64.07
Average Volume (20 Days)	980

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0A87 had revenue of GBP 21.16 billion and earned 535.14 million in profits. Earnings per share was 0.33.

Revenue	21.16B
Gross Profit	13.86B
Operating Income	2.86B
Pretax Income	973.22M
Net Income	535.14M
EBITDA	6.04B
EBIT	2.86B
Earnings Per Share (EPS)	0.33

Balance Sheet

The company has 3.10 billion in cash and 25.69 billion in debt, with a net cash position of -22.59 billion.

Cash & Cash Equivalents	3.10B
Total Debt	25.69B
Net Cash	-22.59B
Net Cash Per Share	n/a
Equity (Book Value)	36.22B
Book Value Per Share	22.93
Working Capital	2.40B

Cash Flow

In the last 12 months, operating cash flow was 5.63 billion and capital expenditures -845.58 million, giving a free cash flow of 4.79 billion.

Operating Cash Flow	5.63B
Capital Expenditures	-845.58M
Free Cash Flow	4.79B
FCF Per Share	n/a

Margins

Gross margin is 65.52%, with operating and profit margins of 13.51% and 2.53%.

Gross Margin	65.52%
Operating Margin	13.51%
Pretax Margin	4.60%
Profit Margin	2.53%
EBITDA Margin	28.53%
EBIT Margin	13.51%
FCF Margin	22.64%

Dividends & Yields

This stock pays an annual dividend of 0.43, which amounts to a dividend yield of 2.70%.

Dividend Per Share	0.43
Dividend Yield	2.70%
Dividend Growth (YoY)	4.18%
Years of Dividend Growth	1
Payout Ratio	277.04%
Buyback Yield	-0.25%
Shareholder Yield	2.45%
Earnings Yield	1.37%
FCF Yield	12.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0A87 has an Altman Z-Score of 1.08 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.08
Piotroski F-Score	6